TITLE

Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer

AUTHOR(S)
Garcia, J. M.; Rodriguez, R.; Dominguez, G.; Silva, J. M.; Provencio, M.; Silva, J.; Colmenarejo, A.; Millan, I.; Muñoz, C.; Salas, C.; Coca, S.; España, P.; Bonilla, F.
PUB. DATE
December 2003
SOURCE
Gut;Dec2003, Vol. 52 Issue 12, p1756
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Survival at the intermediate stage of colorectal cancer (CRC) is less predictable than in the early and advanced stages. Several genetic markers possibly involved in growth and progression of CRC can be used for prognosis. Aims: This study investigated the proportion of allelic loss (loss of heterozygosity (LOH)) at the BRCA1 locus in sporadic CRC and its value in patient prognosis. Patients and methods: A total of 314 patients were investigated for LOH at the BRCA1 locus using polymerase chain reaction by means of three intragenic polymorphic microsatellite markers. Allelic losses were compared with clinicopathological characteristics of patients, recurrence rate, disease free survival (DFS), and overall survival. Results: Twenty six patients were excluded because of microsatellite instability. Of the remaining 288 cases, 244 (84.7%) were informative, with 97 (39.8%) patients bearing BRCA1 LOH. Recurrence rate was higher in patients with LOH (p=0.0003), and DFS was 73.3% (SEM 5.7) at five years in patients without LOH, and 49.2% (7.1) in cases with positive allelic loss (p = 0.0004). Retention of alleles at the BRCA1 locus was associated with a favourable DFS in stages I and II (p<0.05). The presence of LOH was also significantly associated with short overall survival (p=0.02). Multivariate analysis in the complete series showed that stage (p=0.006) and lymph node metastases (⩾4 nodes, p=0.0001; 1-3 nodes, p=0.038) were independent prognostic factors. However, multivariate study by stages revealed that BRCA1 LOH was an independent prognostic factor in stages I and II (p=0.001). Conclusions: BRCA1 LOH is a molecular alteration present in CRC, with unfavourable repercussions for overall survival, that could be considered as an outstanding independent prognostic factor in stages I and II.
ACCESSION #
12940918

 

Related Articles

  • S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer. Li-Yong Huang; Ye Xu; Guo-Xiang Cai; Zu-Qing Guan; Wei-Qi Sheng; Hong-Fen Lu; Li-Qi Xie; Hao-Jie Lu; San-Jun Cai // Annals of Gastroenterology & Hepatology;2011, Vol. 9 Issue 92, p69 

    AIM: To develop lymph node metastasis (LNM)-associated biomarkers for colorectal cancer (CRC) using quantitative proteome analysis. METHODS: Differences in protein expression between primary CRC with LNM (LNM CRC) and without LNM (non-LNM CRC) were assessed using methyl esterification stable...

  • NDST4 Is a Novel Candidate Tumor Suppressor Gene at Chromosome 4q26 and Its Genetic Loss Predicts Adverse Prognosis in Colorectal Cancer. Tzeng, Sheng-Tai; Tsai, Ming-Hong; Chen, Chi-Long; Lee, Jing-Xing; Jao, Tzu-Ming; Yu, Sung-Liang; Yen, Sou-Jhy; Yang, Ya-Chien // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Background: Genomic deletion at tumor suppressor loci is a common genetic aberration in human cancers. The study aimed to explore candidate tumor suppressor genes at chromosome 4q25-q28.2 and to delineate novel prognostic biomarkers associated with colorectal cancer (CRC). Methods: Deletion...

  • Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Toiyama, Yuji; Yasuda, Hiromi; Saigusa, Susumu; Tanaka, Koji; Inoue, Yasuhiro; Goel, Ajay; Kusunoki, Masato // Carcinogenesis;Nov2013, Vol. 34 Issue 11, p2548 

    Slug and Vimentin genes play a critical role in regulating epithelial–mesenchymal transition (EMT) via downregulation of epithelial markers and upregulation of mesenchymal markers. The present study evaluated the clinical significance of Slug and Vimentin expression as potential disease...

  • Variations in short tandem repeats deduced on the basis of the number of repeats and the relationship of these variations with longevity. Liu Hui; Yu Weijian; Deng Xuelian; Liu Qigui // Age;Mar2011, Vol. 33 Issue 1, p63 

    The objective of this study was to investigate the quantitative characteristics of short tandem repeat (STR) variations deduced on the basis of the number of STRs that are beneficial for human survival. The longevity group included 60 nonagenarian subjects, and the control group included 250...

  • Matrix metalloproteinases. Chacko, Geeta // Neurology India;Apr2011, Vol. 59 Issue 2, p224 

    The article discusses the aspects of matrix metalloproteinases (MMPs), which are family of enzymes that govern the extracellular matrix environment. It states that studies of MMP expression at a mRNA level have used the automated real time polymerase chain reaction (RT PCR) and microarray....

  • Tandem PCR: a novel and efficient unit amplification model for the preparation of small DNA fragments. Jianbing Wu; Chunjiang Ye // Molecular Biology Reports;Apr2011, Vol. 38 Issue 4, p2729 

    The present DNA marker preparation with PCR amplification, one primer pair for one target DNA fragment, was very tedious and labor intensive. To develop a simple and efficient system for the preparation of small DNA fragments, a novel PCR amplification pattern was designed and tested, of which...

  • An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population. Gray, O. M.; Abdeen, H.; McDonnell, G. V.; Patterson, C. C.; Graham, C. A.; Hawkins, S. A. // Multiple Sclerosis (13524585);Mar2009, Vol. 15 Issue 3, p299 

    Objective To investigate the possibility that susceptibility loci in multiple sclerosis (MS) have a role in determining the disease outcome in Northern Ireland population. Background The Genetic Analysis of Multiple Sclerosis in Europeans (GAMES) initiative and follow-up refined analysis...

  • Detection of SNCA and FBN1 Methylation in the Stool as a Biomarker for Colorectal Cancer. Li, Wen-han; Zhang, Hao; Guo, Qi; Wu, Xuan-di; Xu, Zi-sen; Dang, Cheng-xue; Xia, Peng; Song, Yong-chun // Disease Markers;2/23/2015, p1 

    Aim. We examined the methylation status of SNCA and FBN1 genes in patients’ paired tissue and stool samples for detection of colorectal cancer (CRC). Patients and Methods. 89 DNA tissue samples (normal/cancer) and corresponding stool samples were analyzed in our study. In addition, 30...

  • Proteoglycans as potential microenvironmental biomarkers for colon cancer. Suhovskih, Anastasia; Aidagulova, Svetlana; Kashuba, Vladimir; Grigorieva, Elvira // Cell & Tissue Research;Sep2015, Vol. 361 Issue 3, p833 

    Glycosylation changes occur widely in colon tumours, suggesting glycosylated molecules as potential biomarkers for colon cancer diagnostics. In this study, proteoglycans (PGs) expression levels and their transcriptional patterns are investigated in human colon tumours in vivo and carcinoma cells...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics